Agilon Health (AGL) Invested Capital (2020 - 2026)

Agilon Health has reported Invested Capital for 7 years, with the latest figure at $277.7 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 56.04% year-over-year to $277.7 million; the trailing twelve-month figure through Mar 2026 stood at $277.7 million (down 56.04% YoY), and the FY2025 full-year result was $258.3 million, down 51.82% from the prior year.
• Invested Capital for Q1 2026 stood at $277.7 million, up from $258.3 million in the prior quarter.
• The five-year high for Invested Capital was $1.1 billion in Q1 2022, with the low at $258.3 million in Q4 2025.
• Historically, Invested Capital has averaged $735.6 million across 5 years, with a median of $699.5 million in 2023.
• Annual changes were most pronounced in 2022 — Invested Capital jumped 474.35% — and 2026, when it sank 56.04%.
• Agilon Health's Invested Capital stood at $1.0 billion in 2022, then slumped by 33.1% to $699.5 million in 2023, then retreated by 23.35% to $536.2 million in 2024, then tumbled by 51.82% to $258.3 million in 2025, then climbed by 7.51% to $277.7 million in 2026.
• The last three Invested Capital figures came in at $277.7 million (Q1 2026), $258.3 million (Q4 2025), and $341.1 million (Q3 2025), per Business Quant data.